0001415889-24-005147.txt : 20240223 0001415889-24-005147.hdr.sgml : 20240223 20240223200634 ACCESSION NUMBER: 0001415889-24-005147 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lin Charles Y CENTRAL INDEX KEY: 0002009852 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39592 FILM NUMBER: 24673264 MAIL ADDRESS: STREET 1: C/O KRONOS BIO, INC. STREET 2: 1300 SO. EL CAMINO REAL, SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kronos Bio, Inc. CENTRAL INDEX KEY: 0001741830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (650) 781-5200 MAIL ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 3 1 form3-02242024_010225.xml X0206 3 2024-02-16 0 0001741830 Kronos Bio, Inc. KRON 0002009852 Lin Charles Y C/O KRONOS BIO, INC. 1300 SO. EL CAMINO REAL, SUITE 400 SAN MATEO CA 94402 false true false false SR VP, RESEARCH & DEVELOPMENT Common Stock 246639 D Stock Option (Right to Buy) 2.53 2029-12-19 Common Stock 152975 D Stock Option (Right to Buy) 28.82 2031-02-15 Common Stock 37030 D Stock Option (Right to Buy) 7.08 2032-02-14 Common Stock 57500 D Stock Option (Right to Buy) 2.09 2033-02-14 Common Stock 81920 D Stock Option (Right to Buy) 1.08 2034-02-14 Common Stock 145795 D 25% of the shares vested on December 20, 2020, and the remaining shares shall vest in 36 equal monthly installments. The shares vest in 48 equal monthly installments beginning on February 16, 2021. The shares vest in 48 equal monthly installments beginning on February 15, 2022. The shares vest in 48 equal monthly installments beginning on February 15, 2023. The shares vest in 48 equal monthly installments beginning on February 15, 2024. /s/ Allison Frisbee, Attorney-in-Fact 2024-02-23 EX-24 2 ex24-02242024_010226.htm ex24-02242024_010226.htm

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Allison Frisbee and Kathryn Adamiak of Kronos Bio, Inc. (the “Company”), signing individually, the undersigned’s true and lawful attorney-in fact and agent to:

(1) execute for and on behalf of the undersigned, an officer, director or holder of 10% of more of a registered class of securities of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such forms or amendments with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact shall no longer be employed by the Company.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26th day of January 2024.


/s/ Charles Y. Lin

(Signature)


Charles Y. Lin, Ph.D.

(Name: Printed or Typed)